Cargando…
Targeting HLA-F suppresses the proliferation of glioma cells via a reduction in hexokinase 2-dependent glycolysis
HLA-F, a nonclassical HLA class I molecule, is required for regulating immune tolerance. In recent years, HLA-F has been found to play a role in a variety of cancers, including glioma (GM). Additionally, high expression of HLA-F predicts the poor overall survival of individuals with GM. However, the...
Autores principales: | Chen, Xin, Sun, Na, Li, Rongqin, Sang, Xuejia, Li, Xueqin, Zhao, Jie, Han, Jing, Yang, Jing, Ikezoe, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040476/ https://www.ncbi.nlm.nih.gov/pubmed/33867844 http://dx.doi.org/10.7150/ijbs.56357 |
Ejemplares similares
-
MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2
por: Wang, Shuang-Jia, et al.
Publicado: (2021) -
Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
por: Yuan, Jian, et al.
Publicado: (2020) -
High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss.
por: Oudard, S., et al.
Publicado: (1996) -
STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells
por: Li, Man, et al.
Publicado: (2017) -
Potassium ions promote hexokinase-II dependent glycolysis
por: Bischof, Helmut, et al.
Publicado: (2021)